T1	PROC 46 66	Estudio de extensión
T2	PROC 71 99	tratamiento de mantenimiento
#1	AnnotatorNotes T2	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T3	DISO 149 200	polineuropatía desmielinizante inflamatoria crónica
#2	AnnotatorNotes T3	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T4	DISO 202 206	CIDP
#3	AnnotatorNotes T4	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T5	PROC 231 275	Estudio de extensión abierto y multicéntrico
T6	PROC 281 312	evaluar la seguridad y eficacia
T7	PROC 343 371	tratamiento de mantenimiento
#4	AnnotatorNotes T7	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T8	DISO 378 429	polineuropatía desmielinizante inflamatoria crónica
#5	AnnotatorNotes T8	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T9	DISO 431 435	CIDP
#6	AnnotatorNotes T9	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T10	DISO 519 542	Enfermedad inflamatoria
T11	PROC 922 958	consentimiento informado por escrito
#7	AnnotatorNotes T11	C0811741; Obtain informed written consent; Health Care Activity
T12	ANAT 547 574	sistema nervioso periférico
#8	AnnotatorNotes T12	C0206417; Peripheral Nervous System; Body System | C1305921; Entire peripheral nervous system; Body System
T13	DISO 602 653	Polineuropatía desmielinizante inflamatoria crónica
#9	AnnotatorNotes T13	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T14	DISO 655 659	CIDP
#10	AnnotatorNotes T14	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T15	DISO 817 821	CIDP
#11	AnnotatorNotes T15	C0393819; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Disease or Syndrome
T16	PROC 844 855	tratamiento
#12	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	DISO 1220 1232	enfermedades
#13	AnnotatorNotes T17	C0012634; Disease; Disease or Syndrome
T18	DISO 1268 1279	alcoholismo
#14	AnnotatorNotes T18	C0001973; Alcoholic Intoxication, Chronic; Mental or Behavioral Dysfunction
T19	DISO 1281 1293	drogadicción
#15	AnnotatorNotes T19	C1510472; Drug Dependence; Mental or Behavioral Dysfunction
T20	CHEM 1312 1324	medicamentos
#16	AnnotatorNotes T20	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T21	PROC 1486 1496	evaluación
#17	AnnotatorNotes T21	C1261322; Evaluation procedure; Health Care Activity
T22	PROC 1036 1050	procedimientos
#18	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T23	CHEM 104 119	inmunoglobulina
#19	AnnotatorNotes T23	C0021027; Immunoglobulins; Amino Acid, Peptide, or Protein · Immunologic Factor
T24	CHEM 132 139	IgPro20
#20	AnnotatorNotes T24	C3181507; IgPro20; Immunologic Factor
T25	CHEM 330 337	IgPro20
#21	AnnotatorNotes T25	C3181507; IgPro20; Immunologic Factor
T26	Date 13 17	2013
T27	Route 120 130	subcutánea
#22	AnnotatorNotes T27	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T28	Duration 193 200	crónica
#23	AnnotatorNotes T28	C0205191; chronic; Temporal Concept
T29	Date 313 326	a largo plazo
T30	Duration 422 429	crónica
#24	AnnotatorNotes T30	C0205191; chronic; Temporal Concept
T31	LIVB 441 450	pacientes
#25	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	Duration 646 653	crónica
#26	AnnotatorNotes T32	C0205191; chronic; Temporal Concept
T33	Route 752 754	SC
T34	PHYS 766 776	recuperado
#27	AnnotatorNotes T34	C2004454; Recovery - healing process; Organism Function
T35	Route 856 858	SC
T39	LIVB 1408 1420	investigador
#28	AnnotatorNotes T39	C0035173; Research Personnel; Professional or Occupational Group
T41	LIVB 1459 1465	sujeto
#29	AnnotatorNotes T41	C0681850; Study Subject; Group
T37	Date 742 751	semana 25
T38	CHEM 1501 1504	PEI
#30	AnnotatorNotes T38	C0013230; Investigational New Drugs; Pharmacologic Substance
T40	DISO 803 810	recaída
#31	AnnotatorNotes T40	C2825055; Recurrence (disease attribute); Pathologic Function
A2	Status T40 History_of
#32	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
#33	AnnotatorNotes T10	 C1290884; Inflammatory disorder; Disease or Syndrome
#34	AnnotatorNotes T33	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
#35	AnnotatorNotes T35	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T42	Neg_cue 1115 1117	no
T43	Observation 1125 1172	realizar la transición directa desde el estudio
A3	Assertion T43 Negated
T44	LIVB 1103 1110	Sujetos
#36	AnnotatorNotes T44	C0681850; Study Subject; Group
T36	Spec_cue 1422 1428	puedan
T45	Observation 1429 1450	incrementar el riesgo
A1	Assertion T45 Speculated
T46	CONC 1468 1478	interferir
A4	Assertion T46 Speculated
#37	AnnotatorNotes T46	C0521102; Interferes with; Functional Concept
R1	Has_Route_or_Mode Arg1:T23 Arg2:T27	
R2	Has_Route_or_Mode Arg1:T24 Arg2:T27	
R3	Used_for Arg1:T23 Arg2:T2	
R4	Used_for Arg1:T24 Arg2:T2	
R5	Has_Duration_or_Interval Arg1:T3 Arg2:T28	
R6	Has_Duration_or_Interval Arg1:T4 Arg2:T28	
R7	Overlap Arg1:T6 Arg2:T29	
R8	Used_for Arg1:T25 Arg2:T7	
R9	Has_Duration_or_Interval Arg1:T8 Arg2:T30	
R10	Has_Duration_or_Interval Arg1:T9 Arg2:T30	
R11	Experiences Arg1:T31 Arg2:T9	
R12	Experiences Arg1:T31 Arg2:T8	
R13	Experiences Arg1:T31 Arg2:T25	
T47	Observation 461 482	completado el estudio
#38	AnnotatorNotes T47	C2732579; Completion of clinical trial; Finding
R15	Before Arg1:T47 Arg2:T25	
R16	Before Arg1:T47 Arg2:T7	
R17	Location_of Arg1:T12 Arg2:T10	
R18	Has_Duration_or_Interval Arg1:T14 Arg2:T32	
R19	Has_Duration_or_Interval Arg1:T13 Arg2:T32	
T48	Observation 688 715	Haber completado el estudio
#39	AnnotatorNotes T48	C2732579; Completion of clinical trial; Finding
R20	Overlap Arg1:T48 Arg2:T37	
R21	Before Arg1:T40 Arg2:T34	
R22	Before Arg1:T15 Arg2:T40	
R23	Overlap Arg1:T34 Arg2:T16	
R24	Has_Route_or_Mode Arg1:T16 Arg2:T35	
R25	Has_Route_or_Mode Arg1:T16 Arg2:T33	
T49	Observation 964 988	participar en el estudio
#40	AnnotatorNotes T49	C1278516; Patient participation status; Finding (?)
R26	Before Arg1:T11 Arg2:T49	
R27	Before Arg1:T11 Arg2:T22	
R30	Negation Arg1:T42 Arg2:T43	
T50	Quantifier_or_Qualifier 1213 1219	nuevas
#41	AnnotatorNotes T50	C0205314; New; Qualitative Concept
R31	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T50	
T51	Observation 1296 1324	uso indebido de medicamentos
T52	Observation 1337 1364	participación en el estudio
#42	AnnotatorNotes T52	C1278516; Patient participation status; Finding (?)
R32	Overlap Arg1:T51 Arg2:T52	
R33	Used_for Arg1:T20 Arg2:T51	
R34	Overlap Arg1:T19 Arg2:T52	
R35	Overlap Arg1:T18 Arg2:T52	
R36	Overlap Arg1:T17 Arg2:T52	
#43	AnnotatorNotes T51	C5229524; Misuse of medication; Finding
R37	Speculation Arg1:T36 Arg2:T45	
R38	Before Arg1:T17 Arg2:T45	
R39	Before Arg1:T18 Arg2:T45	
R40	Before Arg1:T19 Arg2:T45	
R41	Before Arg1:T51 Arg2:T45	
R42	Experiences Arg1:T41 Arg2:T45	
R44	Experiences Arg1:T41 Arg2:T51	
R45	Experiences Arg1:T41 Arg2:T20	
R46	Experiences Arg1:T41 Arg2:T19	
R47	Experiences Arg1:T41 Arg2:T18	
R48	Experiences Arg1:T41 Arg2:T17	
R49	Speculation Arg1:T36 Arg2:T46	
R50	Experiences Arg1:T41 Arg2:T38	
R51	Experiences Arg1:T41 Arg2:T21	
#44	AnnotatorNotes T29	C0443252; Long-term; Temporal Concept
#45	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity
#46	AnnotatorNotes T45	C4699158; Increased risk; Finding
A5	Experiencer T31 Patient
A6	Experiencer T44 Patient
A7	Experiencer T39 Other
A8	Experiencer T41 Patient
